Home Newsfeeds Barclays Downgrades Kornit Digital to Equal-Weight, Lowers Price Target to $28

Barclays Downgrades Kornit Digital to Equal-Weight, Lowers Price Target to $28

Barclays analyst Tavy Rosner downgrades Kornit Digital (NASDAQ:KRNT) from Overweight to Equal-Weight and lowers the price target from $34 to $28.

byBenzinga Newsdesk

February 16, 2023

1 minute read

Barclays analyst Tavy Rosner downgrades Kornit Digital (NASDAQ:KRNT) from Overweight to Equal-Weight and lowers the price target from $34 to $28.

Analyst Ratings

Deep Dive Into Travere Therapeutics Stock: Analyst Perspectives (7 Ratings)

By Benzinga Insights

February 16, 10:00 AM

In the last three months, 7 analysts have published ratings on Travere Therapeutics (NASDAQ:TVTX), offering a diverse range…

TVTX

News

REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet Age-Related Macular Degeneration (AMD)

By Benzinga Newsdesk

March 28, 7:09 AM

REGENXBIO Inc. (NASDAQ:RGNX) today announced the publication of results from the Phase I/IIa trial evaluating the safety and tolerability of a single dose of subretinal ABBV-RGX-314 for the treatment of wet age-related

ABBV

Molekule And Aura Expand In Global Education Market With Multiple Deployments And Orders; Education Industry Sales Reach Nearly $4M

By Benzinga Newsdesk

April 28, 9:09 AM

Education industry sales reach nearly $4MInstalled base hits over 11,000 air purifiers in schools, including some of the largest school districts in the U.S., eliminating SARS-CoV-2, RSV, H1N1 Flu Virus, bacteria and

MKUL